Biologics Market Research Reports & Industry Analysis
The biologics industry includes a wide range of therapeutic products derived from biological sources and is a fundamental part of modern healthcare. Biologics play a vital role in advancing treatments for various diseases and conditions. MarketResearch.com offers a comprehensive collection of biologics industry reports to provide valuable insights into the most recent market trends, challenges, and opportunities to watch.
Biologics Market Growth Forecasts
- Access detailed information about a variety of distinct market segments, such as recombinant proteins, vaccines, and more.
- Obtain biologics market sizing and growth projections to gain a clear understanding of market potential and outlook.
- Analyze leading players and competitor strategies to stay one step ahead in a competitive market.
The MarketResearch.com Advantage
MakretResearch.com has been a trailblazer in the field of market research for more than two decades and continues to serve many of the largest life science and biotech companies in the world. With MarketResearch.com’s reliable data-driven insights, you can make informed decisions to guide your business towards success. Choose MarketResearch.com and gain the edge today.
Biologics Industry Research & Market Reports
-
Burn Care Market by Product (Advanced (Collagen, Film, Hydrogel, Foam, Alginate Dressings), Therapy Devices (Debridement, NPWT), Biologics, Traditional), Burn Degree (First, Second, Third-degree Burns), End User (Hospitals, ASCs) - Global Forecast to 2030
... demand for effective treatment technologies, contributing to market growth. Advancements in burn care technology, heightened awareness of the importance of early intervention, and supportive government initiatives are also facilitating this growth. ""The advanced burn dressings ... Read More
-
Cell Cryopreservation Market, By Product Type (Cryoprotectant Agents and Equipment), By Application (Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes, Others), By End User (Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobank, IVF clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and ... Read More
-
Biological and Biochemical Product Manufacturing in China - Industry Market Research Report
... of 10.6% in 2023 alone, when profit will be 11.7%. The industry has benefited from the development of the national economy, rising household disposable incomes and increasing investment in the healthcare sector by the government. ... Read More
-
Inflammatory Bowel Disease Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... will reach US$23.01 billion in 2025 and further expand to US$32.6 billion by 2032, growing at a CAGR of 5.10% during the forecast period. This growth trajectory is supported by increasing demand for more targeted, ... Read More
-
Oral Biologics & Biosimilar Drugs Global Market Report 2025
... biologics & biosimilar drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Cancer biologics Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Single-use Bioprocessing System Market 2025-2029
... bioprocessing system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
... that will save countless hours of research. Key Findings: Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $77,985,958,669 by 2031. Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.), including Average EBITDA, ... Read More
-
Biological Drugs
... CAGR of 9.1% over the analysis period 2024-2030. Therapeutic Protein, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$289.1 Billion by the end of the analysis ... Read More
-
Agricultural Biologicals Testing
... at a CAGR of 8.8% over the analysis period 2024-2030. Biopesticides, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Agricultural Biologicals
... CAGR of 12.4% over the analysis period 2024-2030. Biopesticides, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$21.8 Billion by the end of the analysis period. ... Read More
-
Allografts
... 6.9% over the analysis period 2024-2030. Demineralized Bone Matrix (DBM), one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$488.4 Million by the end of the analysis ... Read More
-
Biopharmaceuticals Manufacturing Consumables Testing
... 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Compendial & Multi Compendial Laboratory Testing, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More
-
Plasma Protein Therapeutics
... at a CAGR of 4.8% over the analysis period 2024-2030. Albumin, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$9.3 Billion by the end of the ... Read More
-
Autoinjectors
... 15.9% over the analysis period 2024-2030. Rheumatoid Arthritis Therapy, one of the segments analyzed in the report, is expected to record a 15.8% CAGR and reach US$47.6 Billion by the end of the analysis period. ... Read More
-
Peptide Synthesis
... CAGR of 4.3% over the analysis period 2024-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the analysis period. ... Read More
-
Biopharmaceutical Logistics
... CAGR of 4.8% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$37.9 Billion by the end of the ... Read More
-
Fill Finish Manufacturing
... at a CAGR of 8.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$13.7 Billion by the end of the ... Read More
-
Ampoules Packaging
... CAGR of 6.2% over the analysis period 2024-2030. Glass Packaging, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$5.6 Billion by the end of the analysis ... Read More
-
Biologics
... 8.2% over the analysis period 2024-2030. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$271.3 Billion by the end of the analysis period. ... Read More
-
Biopharmaceutical Fermentation Systems
... at a CAGR of 4.5% over the analysis period 2024-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by the end of ... Read More
-
Spine Biologics
... CAGR of 4.4% over the analysis period 2024-2030. Spinal Allografts, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.4 Billion by the end of the analysis ... Read More
-
Bioprocess Containers
... CAGR of 23.7% over the analysis period 2024-2030. 2D Bioprocess Containers, one of the segments analyzed in the report, is expected to record a 27.1% CAGR and reach US$22.3 Billion by the end of the ... Read More
-
Virus Filtration Products
... at a CAGR of 12.4% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$7.8 Billion by the end ... Read More
-
Generic Injectables
... CAGR of 11.8% over the analysis period 2024-2030. Large Molecule Injectables, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$145.9 Billion by the end of the ... Read More
Research Assistance
